Eastover Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Eastover Investment Advisors's BMY Position: Q4 2023 in Review
Eastover Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 73,415 shares — an estimated $4.26M sold.
Eastover Investment Advisors first reported a position in BMY in Q1 2020 and held it in 15 quarters. The position peaked at $5.34M in Q1 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.
- Eastover Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
- Eastover Investment Advisors sold 73,415 Bristol-Myers Squibb shares in Q4 2023, an estimated $4.26M.
- Eastover Investment Advisors first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 15 quarters.
- Eastover Investment Advisors's Bristol-Myers Squibb position peaked at $5.34M in Q1 2022.
- 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.
Based on Eastover Investment Advisors's 13F filing for Q4 2023, filed 18 Jan 2024.